ÐÂÎÅ×ÊѶ
ÄÐÐÔµÄÇ¿Ê¢£¬ £¬£¬£¬£¬£¬ £¬£¬ÔÚÓÚ´ÓÈÝ¡ª¡ª¡ªÏ²±¨£¡º£ÄÚÊ׸ö£¡Î÷°àÑÀÔÑÐÈë¿ÚèÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº»ñÅúÉÏÊУ¡
ÈÕÆÚ£º
2026Äê04ÔÂ03ÈÕ 14:35
èÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº£¨ÐÒ·ö½¡®£©ÉÏÊÐÉêÇëÕýʽ»ñÅú¡£¡£¡£¡£ ¡£¡£¡£×÷Ϊº£ÄÚÊ׸ö¿Ú·þ»ìÐüÒº¼ÁÐ͵ÄÎ÷µØÄÇ·Ç£¬ £¬£¬£¬£¬£¬ £¬£¬Õâ¿îÓÉÎ÷°àÑÀÔÑÐÉú²úµÄ²úÆ·£¬ £¬£¬£¬£¬£¬ £¬£¬²»µ«Ìî²¹ÁËED£¨²ªÆð¹¦Ð§ÕÏ°£©ÖÎÁÆÁìÓòµÄ¼ÁÐÍ¿Õȱ£¬ £¬£¬£¬£¬£¬ £¬£¬¸ü±ê¼Ç×ÅÄÐÐÔ¿µ½¡ÖÎÀíÂõÈëÁ˾«×¼¿ØÁ¿¡¢ÌåÑéÓÅÏȵÄн׶Ρ£¡£¡£¡£ ¡£¡£¡£Ëü¼È·ÇÈ«ÐÂÒòËØ£¬ £¬£¬£¬£¬£¬ £¬£¬Ò²·ÇÊ׷£¬ £¬£¬£¬£¬£¬ £¬£¬¶øÊÇÖ±»÷»¼Õßδ±»Öª×ãµÄÓÃÒ©ÐèÇó£¬ £¬£¬£¬£¬£¬ £¬£¬ÒÔ¸ÄÁ¼ÐÍÐÂÒ©µÄ×Ë̬£¬ £¬£¬£¬£¬£¬ £¬£¬ÖØнç˵·þÒ©ÌåÑé——¸üÓÐÓ㬠£¬£¬£¬£¬£¬ £¬£¬¸üÌåÃ棬 £¬£¬£¬£¬£¬ £¬£¬¸ü´ÓÈÝ¡£¡£¡£¡£ ¡£¡£¡£
Ò»¡¢Êг¡ÏÖ×´£ºEDÖÎÁÆÐèÇóÏÔÖø£¬ £¬£¬£¬£¬£¬ £¬£¬¹Å°åÓÃÒ©Í´µãÈÔ´æ
Ïֽ׶Î,EDÒѳÉΪӰÏìÄÐÐÔÉúÑÄÖÊÁ¿µÄÖ÷ÒªÎÊÌâÖ®Ò»¡£¡£¡£¡£ ¡£¡£¡£ÔÚÎÒ¹úÓÐ×ÅÖØ´óµÄ»¼Õß»ùÊý¡£¡£¡£¡£ ¡£¡£¡£¾Ý¹ûÕæÊý¾ÝÏÔʾ£¬ £¬£¬£¬£¬£¬ £¬£¬ÎÒ¹úED»¼ÕßÈËÊýÔ¼1.4ÒÚÈË¡£¡£¡£¡£ ¡£¡£¡£¾Ý¡¶2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé¡·ÏÔʾ£¬ £¬£¬£¬£¬£¬ £¬£¬31-40ËêÄÐÐÔÕ¼±È44.79%£¬ £¬£¬£¬£¬£¬ £¬£¬21-30ËêȺÌåÒ²µÖ´ï38.03%£¬ £¬£¬£¬£¬£¬ £¬£¬·ºÆðÄêÇữÇ÷ÊÆ¡£¡£¡£¡£ ¡£¡£¡£
´ÓÊг¡¹æÄ£À´¿´£¬ £¬£¬£¬£¬£¬ £¬£¬EDÒ©ÎïÈüµÀÌåÁ¿¿É¹Û£¬ £¬£¬£¬£¬£¬ £¬£¬¶øÎ÷µØÄÇ·ÇÔÚËùÓÐEDÀàÒ©ÎïÊг¡Õ¼±È¶ÀÙÆ°ÁÍ·£¬ £¬£¬£¬£¬£¬ £¬£¬2024ÄêÕ¼±È¸ß´ï71.96%¡£¡£¡£¡£ ¡£¡£¡£×÷ΪPDE5ÒÖÖƼÁµÄ½¹µãÆ·À࣬ £¬£¬£¬£¬£¬ £¬£¬Î÷µØÄǷǸüÊDZ»º£ÄÚÍâ¶àÏîȨÍþÖ¸ÄÏ£¨È硶²ªÆð¹¦Ð§ÕÏ°Õï¶ÏÓëÖÎÁÆÖ¸ÄÏ¡·¡¶Å·ÖÞÃÚÄòѧ»áÐÔÓëÉúÖ³¿µ½¡Ö¸ÄÏ¡·µÈ£©ÁÐΪEDÖÎÁƵÄÊ×Ñ¡Ò©Î £¬£¬£¬£¬£¬ £¬£¬ÆäÓÐÓÃÐÔÓëÇå¾²ÐÔÒÑ»ñµÃÆÕ±éÑéÖ¤¡£¡£¡£¡£ ¡£¡£¡£
Ö»¹Ü¿Ú·þPDE5ÒÖÖƼÁÊÇEDÖÎÁƵÄÖ÷Á÷Ñ¡Ôñ£¬ £¬£¬£¬£¬£¬ £¬£¬ÇÒ38.64%µÄÄÐÐÔÔø·þÓùý¿¹EDÒ©Îï1£¬ £¬£¬£¬£¬£¬ £¬£¬µ«¹Å°åƬ¼ÁµÄÍ´µãʼÖÕÄÑÒÔ½â¾ö£¬ £¬£¬£¬£¬£¬ £¬£¬³ÉΪ»¼ÕßÓÃÒ©µÄÒþÐÎÃż÷£º
¼ÁÁ¿Àο¿£ºÏÖÓе¥ºÐ°ü×°¼ÁÐͼÁÁ¿¾ùÒÑÀο¿£¬ £¬£¬£¬£¬£¬ £¬£¬ÎÞ·¨Æ¥Åä¸öÌ廯ÐèÇ󣻣»£»£»£»£»
ÐèË®ËÍ·þ£ºÎÞ·¨Öª×ãÎÞË®Ìõ¼þÏÂËæʱËæµØÔ½·¢±ã½Ý¸øÒ©£»£»£»£»£»£»
Òþ˽ÞÏÞΣºÒ©Æ¬°ü×°Ò×̻¶Òþ˽£¬ £¬£¬£¬£¬£¬ £¬£¬ÓÈÆäÔÚÉç½»³¡¾°ÏÂÓÃÒ©±ãµ±ÐÔ´ó·ùϽµ£»£»£»£»£»£»
ÍÌÑÊÕÏ°£ºÔ¼40.2£¥µÄÄÐÐÔ±£´æÍÌÑÊÄÑÌâ2£¬ £¬£¬£¬£¬£¬ £¬£¬Æ¬¼ÁÄÑÒÔÖª×ãÍÌÑÊÕÏ°ÕßÓÃÒ©ÐèÇ󡣡£¡£¡£ ¡£¡£¡£
¶þ¡¢ÐÒ·ö½¡®£ºÒÔ¸ÄÁ¼ÊµÏÖÌåÑéÉý¼¶¾«×¼»÷ÖÐÁÙ´²Í´µã
ÐÒ·ö½¡®µÄÉÏÊУ¬ £¬£¬£¬£¬£¬ £¬£¬ÕýÊǶÔÕâËÄ´óÍ´µãµÄ¾«×¼»ØÓ¦£º
¾«×¼¼ÁÁ¿¶¨ÖÆ£º¼ÁÁ¿¿Éƾ֤ÐèÇóÎÞаµ÷Àí£¬ £¬£¬£¬£¬£¬ £¬£¬25-100mg×ÔÓɵ÷½â£¬ £¬£¬£¬£¬£¬ £¬£¬Æ¥Åä¸öÐÔ»¯ÐèÇ󣻣»£»£»£»£»
ʹÓÃÀû±ã¿ì½Ý£ºÎ¢·Û»¯Êèɢϵͳ£¬ £¬£¬£¬£¬£¬ £¬£¬ÎÞÐèË®ËÍ·þ£¬ £¬£¬£¬£¬£¬ £¬£¬ËæʱËæµØÍê³É¸øÒ©£¬ £¬£¬£¬£¬£¬ £¬£¬ÊÊÅä¶àÔªÉúÑij¡¾°£»£»£»£»£»£»
È«ÐÂÓÃÒ©ÌåÑ飺°Ñ“͵͵ÃþÃþÍÌƬ”Éý¼¶Îª“×Æ˸Õý´ó¿ÚÅç¸øÒ©”£¬ £¬£¬£¬£¬£¬ £¬£¬½â¾öÉç½»³¡¾°µÄÒþ˽ÞÏÞΡ£¡£¡£¡£ ¡£¡£¡£
ÊÊÓÃÈËȺÆձ飺ÌØÊâÊʺÏÍÌÑÊÄÑÌâ¡¢Ðè׼ȷ¼ÁÁ¿µ÷½âµÄʹÓÃÕß
Èý¡¢´Ó“ÓÐÓÔµ½“ºÃÓÔ£ºÒ»³¡¹ØÓÚ·þÒ©ÌåÑéµÄÀíÄî¸ïÃü
ÐÒ·ö½¡®µÄ»ñÅú£¬ £¬£¬£¬£¬£¬ £¬£¬Ô¶·ÇÒ»´Î¼òÆӵļÁÐ͸ÄÁ¼£¬ £¬£¬£¬£¬£¬ £¬£¬¶øÊÇÒ»³¡¹ØÓÚEDÖÎÁƵÄÀíÄî¸ïÃü——ÎÒÃÇÕýÔÚÖØнç˵ʲô²ÅÊÇ“ºÃÒ©”¡£¡£¡£¡£ ¡£¡£¡£
ºã¾ÃÒÔÀ´£¬ £¬£¬£¬£¬£¬ £¬£¬Ò½Ò©ÐÐÒµÖ´×ÅÓÚ×·ÇóÒ©ÎïµÄ“ÓÐÓÃÐÔ”£¬ £¬£¬£¬£¬£¬ £¬£¬È´ÍùÍùºöÂÔÁË“¿ÉÓÃÐÔ”¡£¡£¡£¡£ ¡£¡£¡£µ±»¼ÕßÐèÒªêþҩƬ¡¢ÕÒË®±¡¢ÅÌËãʱ¼ä¡¢ÌÓ±ÜÑÛ¹âʱ£¬ £¬£¬£¬£¬£¬ £¬£¬Ò©ÎïµÄÁÆЧÒÑÔÚ²ã²ãÕÛËðÖдòÁËÕÛ¿Û¡£¡£¡£¡£ ¡£¡£¡£
ÐÒ·ö½¡®µÄ·ºÆ𣬠£¬£¬£¬£¬£¬ £¬£¬±ê¼Ç×ÅEDÖÎÁÆÕýʽ´Ó“·þÒ©Öβ¡”µÄ1.0ʱ´ú£¬ £¬£¬£¬£¬£¬ £¬£¬ÂõÈë“ÌåÑéÓÅÏÈ”µÄ2.0ʱ´ú¡£¡£¡£¡£ ¡£¡£¡£Õâ²»µ«ÊÇÊÖÒÕµÄÇ°½ø£¬ £¬£¬£¬£¬£¬ £¬£¬¸üÊǼÛÖµ¹ÛµÄת±ä£º
-
´Ó“»¼Õß˳ӦҩÎ½“Ò©Îï˳Ӧ»¼Õß”
-
´Ó“¼òµ¥¼ÁÁ¿”µ½“¸öÐÔ»¯¼Æ»®”
-
´Ó“Ò½ÁƳ¡¾°”µ½“ÉúÑij¡¾°”
-
´Ó“Öβ¡”µ½“ÖÎÐÄ”
“¸úÓÐÇéÈË×ö¿ìÀÖÊ£¬ £¬£¬£¬£¬£¬ £¬£¬±ðÎÊÊǽÙÊÇÔµ¡£¡£¡£¡£ ¡£¡£¡£”Õâ¾äÀ´×Ô¡¶Á÷¹â°¿Ïè¡·µÄ¸è´Ê£¬ £¬£¬£¬£¬£¬ £¬£¬µÀ¾¡ÁËÈËÊÀÇé°®µÄ´¿´âÓëäìÈ÷¡£¡£¡£¡£ ¡£¡£¡£¶øÒ»·Ý´ÓÈݵĵ×Æø£¬ £¬£¬£¬£¬£¬ £¬£¬ÕýÊÇÕâ“¿ìÀÖÊ”×îºÃµÄ×îÏÈ¡£¡£¡£¡£ ¡£¡£¡£
ÏÖÔÚ£¬ £¬£¬£¬£¬£¬ £¬£¬ÐÒ·ö½¡® ÔÚÒ½Ò©ÁìÓòÕÒµ½ÁËеÄ×¢½Å——ÕæÕýµÄÖÎÁÆ£¬ £¬£¬£¬£¬£¬ £¬£¬Ó¦µ±Èû¼ÕßÔÚ×·Çó¿µ½¡µÄõ辶ÉÏ£¬ £¬£¬£¬£¬£¬ £¬£¬±£ÓÐÓ¦ÓеĴÓÈÝÓëÌåÃæ¡£¡£¡£¡£ ¡£¡£¡£
ÎÒÃÇÆÚ´ýÓë¸÷½çЯÊÖ£¬ £¬£¬£¬£¬£¬ £¬£¬ÈÃÕⳡʼÓÚ¼ÁÐ͵ÄÀå¸ï£¬ £¬£¬£¬£¬£¬ £¬£¬×îÖÕÒý·¢Õû¸öÐÐÒµ¶Ô»¼ÕßÌåÑéµÄÖØйØ×¢¡£¡£¡£¡£ ¡£¡£¡£ÓÉÓÚ£¬ £¬£¬£¬£¬£¬ £¬£¬×îºÃµÄÒ©£¬ £¬£¬£¬£¬£¬ £¬£¬²»µ«ÊÇÄÜÈò¡ÈËȬÓúµÄÒ©£¬ £¬£¬£¬£¬£¬ £¬£¬¸üÊÇÈò¡ÈËÔ¸Òâ¼á³Ö·þÓõÄÒ©¡£¡£¡£¡£ ¡£¡£¡£
×ÊÁÏȪԴ
1¡¢2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé
2¡¢Pharmacokinetic Parameters of a Novel SildenafiOral Liquid Suspension Administered to HealthyAdult Men Under Fasted Conditions
3¡¢ÖйúÌض¨ÈËȺÍÌÑʹ¦Ð§ÕÏ°µÄÊ¢Ðв¡Ñ§ÊӲ챨¸æ.ÖлªÎïÀíҽѧÓ뿵ÅÓºêÔ¸2017Äê12ÔµÚ39¾íµÚ12ÆÚ
4¡¢Ã×ÄÚÍøÊý¾Ý¿â¡¢²úÆ·ÁÙ´²Ñо¿Êý¾Ý
Ïà¹ØÍƼö
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ